IMPROVEMENTS OF THE RELATIONSHIP BETWEEN PHYSICIANS AND DRUG COMPANIES

Dr. Micheline Khazzaka

Abstract


There is always a high need for more strengthening the ethical norms regulating the interaction between physicians and pharmaceutical industries. The improvement of policies and regulations minimize healthcare cost on patients. For this purpose, this paper proposes several guidelines. 


Keywords


Cost, Patients, Pharmaceutical Companies, Physicians, Regulations.

Full Text:

PDF

References


Brett, A. S., Burr, W., & Moloo, J. (2003). Are gifts from pharmaceutical companies ethically problematic?: a survey of physicians. Archives of internal medicine, 163(18), 2213-2218.

Chimonas, S., Brennan, T.A., & Rothman, D.J. (2007). Physicians and drug representatives: exploring the dynamics of the relationship. Society of General Internal Medicine, 22(2), 184-190.

Goyal, R., & Pareek, P. (2013). A review article on prescription behavior of doctors, influenced by the medical representative in Rajasthan, India. IOSR Journal of Business and Management, 8(1), 56-60.

Harris, I. (2001). Closing the door on sample closets. Minn Med, 84(1), 17-20.

Leffler, K. B. (1981). Persuasion or information? The economics of prescription drug advertising. The Journal of Law and Economics, 24(1), 45-74.

Noordin, M.I. (2012). Ethics in pharmaceutical issues, contemporary issues in bioethics.

Sah, S., Moore, D. A., & MacCoun, R. (2013). Cheap talk and credibility: The consequences of confidence and accuracy on advisor credibility and persuasiveness, Organizational Behavior and Human Decision Processes, 121( 2), 246-255


Refbacks

  • There are currently no refbacks.